Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Clinical trial NCT00871117 · COMPLETED

Trial details

NCT number: NCT00871117
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tetanus Acellular Pertussis Diphtheria

Start date: 2009-03-31
Primary completion: 2010-01-15
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.